Novel Anti-inflammatory and Vasodilatory ω-3 Endocannabinoid Epoxide Regioisomers

Lauren N. Carnevale, Aditi Das

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Accumulating evidence suggests that diets rich in ω-3 polyunsaturated fatty acids (PUFAs) offer protection against vascular inflammation, neuroinflammation, hypertension, and thrombosis. Recently, biochemical studies have demonstrated that these benefits are partially mediated by their conversion to ω-3 endocannabinoid epoxide metabolites. These lipid metabolites originate from the epoxidation of ω-3 endocannabinoids, docosahexanoyl ethanolamide (DHEA) and eicosapentaenoyl ethanolamide (EPEA) by cytochrome P450 (CYP) epoxygenases to form epoxydocosapentaenoic acid-ethanolamides (EDP-EAs) and epoxyeicosatetraenoic acid-ethanolamides (EEQ-EAs), respectively. The EDP-EAs and EEQ-EAs are endogenously produced in rat brain and peripheral organs. Additionally, EDP-EAs and EEQ-EAs dose-dependently decrease pro-inflammatory IL-6 cytokine and increased anti-inflammatory IL-10 cytokine. Furthermore, the EEQ-EAs and EDP-EAs attenuate angiogenesis and cell migration in cancer cells, induce vasodilation in bovine coronary arteries, and reciprocally regulate platelet aggregation in washed human platelets. Taken together, the ω-3 endocannabinoid epoxides represent a new class of dual acting molecules that display unique pharmacological properties.

Original languageEnglish (US)
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer New York LLC
Pages219-232
Number of pages14
DOIs
StatePublished - Jan 1 2019

Publication series

NameAdvances in Experimental Medicine and Biology
Volume1161
ISSN (Print)0065-2598
ISSN (Electronic)2214-8019

Fingerprint

Endocannabinoids
Epoxy Compounds
Anti-Inflammatory Agents
Acids
Metabolites
Platelets
Cytokines
Epoxidation
Nutrition
Unsaturated Fatty Acids
Platelet Aggregation
Vasodilation
Interleukin-10
Cytochrome P-450 Enzyme System
Cell Movement
Blood Vessels
Rats
Interleukin-6
Brain
Coronary Vessels

Keywords

  • Cannabinoid receptors 1 and 2
  • Cytochrome p450
  • Endocannabinoid
  • Epoxyeicosatrienoic acids
  • Epoxygenase
  • Neuroinflammation
  • Omega-3 fatty acids

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Carnevale, L. N., & Das, A. (2019). Novel Anti-inflammatory and Vasodilatory ω-3 Endocannabinoid Epoxide Regioisomers. In Advances in Experimental Medicine and Biology (pp. 219-232). (Advances in Experimental Medicine and Biology; Vol. 1161). Springer New York LLC. https://doi.org/10.1007/978-3-030-21735-8_17

Novel Anti-inflammatory and Vasodilatory ω-3 Endocannabinoid Epoxide Regioisomers. / Carnevale, Lauren N.; Das, Aditi.

Advances in Experimental Medicine and Biology. Springer New York LLC, 2019. p. 219-232 (Advances in Experimental Medicine and Biology; Vol. 1161).

Research output: Chapter in Book/Report/Conference proceedingChapter

Carnevale, LN & Das, A 2019, Novel Anti-inflammatory and Vasodilatory ω-3 Endocannabinoid Epoxide Regioisomers. in Advances in Experimental Medicine and Biology. Advances in Experimental Medicine and Biology, vol. 1161, Springer New York LLC, pp. 219-232. https://doi.org/10.1007/978-3-030-21735-8_17
Carnevale LN, Das A. Novel Anti-inflammatory and Vasodilatory ω-3 Endocannabinoid Epoxide Regioisomers. In Advances in Experimental Medicine and Biology. Springer New York LLC. 2019. p. 219-232. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-3-030-21735-8_17
Carnevale, Lauren N. ; Das, Aditi. / Novel Anti-inflammatory and Vasodilatory ω-3 Endocannabinoid Epoxide Regioisomers. Advances in Experimental Medicine and Biology. Springer New York LLC, 2019. pp. 219-232 (Advances in Experimental Medicine and Biology).
@inbook{02d1c88fe28d4567afbdcbdb0761bd80,
title = "Novel Anti-inflammatory and Vasodilatory ω-3 Endocannabinoid Epoxide Regioisomers",
abstract = "Accumulating evidence suggests that diets rich in ω-3 polyunsaturated fatty acids (PUFAs) offer protection against vascular inflammation, neuroinflammation, hypertension, and thrombosis. Recently, biochemical studies have demonstrated that these benefits are partially mediated by their conversion to ω-3 endocannabinoid epoxide metabolites. These lipid metabolites originate from the epoxidation of ω-3 endocannabinoids, docosahexanoyl ethanolamide (DHEA) and eicosapentaenoyl ethanolamide (EPEA) by cytochrome P450 (CYP) epoxygenases to form epoxydocosapentaenoic acid-ethanolamides (EDP-EAs) and epoxyeicosatetraenoic acid-ethanolamides (EEQ-EAs), respectively. The EDP-EAs and EEQ-EAs are endogenously produced in rat brain and peripheral organs. Additionally, EDP-EAs and EEQ-EAs dose-dependently decrease pro-inflammatory IL-6 cytokine and increased anti-inflammatory IL-10 cytokine. Furthermore, the EEQ-EAs and EDP-EAs attenuate angiogenesis and cell migration in cancer cells, induce vasodilation in bovine coronary arteries, and reciprocally regulate platelet aggregation in washed human platelets. Taken together, the ω-3 endocannabinoid epoxides represent a new class of dual acting molecules that display unique pharmacological properties.",
keywords = "Cannabinoid receptors 1 and 2, Cytochrome p450, Endocannabinoid, Epoxyeicosatrienoic acids, Epoxygenase, Neuroinflammation, Omega-3 fatty acids",
author = "Carnevale, {Lauren N.} and Aditi Das",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/978-3-030-21735-8_17",
language = "English (US)",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York LLC",
pages = "219--232",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - CHAP

T1 - Novel Anti-inflammatory and Vasodilatory ω-3 Endocannabinoid Epoxide Regioisomers

AU - Carnevale, Lauren N.

AU - Das, Aditi

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Accumulating evidence suggests that diets rich in ω-3 polyunsaturated fatty acids (PUFAs) offer protection against vascular inflammation, neuroinflammation, hypertension, and thrombosis. Recently, biochemical studies have demonstrated that these benefits are partially mediated by their conversion to ω-3 endocannabinoid epoxide metabolites. These lipid metabolites originate from the epoxidation of ω-3 endocannabinoids, docosahexanoyl ethanolamide (DHEA) and eicosapentaenoyl ethanolamide (EPEA) by cytochrome P450 (CYP) epoxygenases to form epoxydocosapentaenoic acid-ethanolamides (EDP-EAs) and epoxyeicosatetraenoic acid-ethanolamides (EEQ-EAs), respectively. The EDP-EAs and EEQ-EAs are endogenously produced in rat brain and peripheral organs. Additionally, EDP-EAs and EEQ-EAs dose-dependently decrease pro-inflammatory IL-6 cytokine and increased anti-inflammatory IL-10 cytokine. Furthermore, the EEQ-EAs and EDP-EAs attenuate angiogenesis and cell migration in cancer cells, induce vasodilation in bovine coronary arteries, and reciprocally regulate platelet aggregation in washed human platelets. Taken together, the ω-3 endocannabinoid epoxides represent a new class of dual acting molecules that display unique pharmacological properties.

AB - Accumulating evidence suggests that diets rich in ω-3 polyunsaturated fatty acids (PUFAs) offer protection against vascular inflammation, neuroinflammation, hypertension, and thrombosis. Recently, biochemical studies have demonstrated that these benefits are partially mediated by their conversion to ω-3 endocannabinoid epoxide metabolites. These lipid metabolites originate from the epoxidation of ω-3 endocannabinoids, docosahexanoyl ethanolamide (DHEA) and eicosapentaenoyl ethanolamide (EPEA) by cytochrome P450 (CYP) epoxygenases to form epoxydocosapentaenoic acid-ethanolamides (EDP-EAs) and epoxyeicosatetraenoic acid-ethanolamides (EEQ-EAs), respectively. The EDP-EAs and EEQ-EAs are endogenously produced in rat brain and peripheral organs. Additionally, EDP-EAs and EEQ-EAs dose-dependently decrease pro-inflammatory IL-6 cytokine and increased anti-inflammatory IL-10 cytokine. Furthermore, the EEQ-EAs and EDP-EAs attenuate angiogenesis and cell migration in cancer cells, induce vasodilation in bovine coronary arteries, and reciprocally regulate platelet aggregation in washed human platelets. Taken together, the ω-3 endocannabinoid epoxides represent a new class of dual acting molecules that display unique pharmacological properties.

KW - Cannabinoid receptors 1 and 2

KW - Cytochrome p450

KW - Endocannabinoid

KW - Epoxyeicosatrienoic acids

KW - Epoxygenase

KW - Neuroinflammation

KW - Omega-3 fatty acids

UR - http://www.scopus.com/inward/record.url?scp=85072706458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072706458&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-21735-8_17

DO - 10.1007/978-3-030-21735-8_17

M3 - Chapter

C2 - 31562632

AN - SCOPUS:85072706458

T3 - Advances in Experimental Medicine and Biology

SP - 219

EP - 232

BT - Advances in Experimental Medicine and Biology

PB - Springer New York LLC

ER -